Jaipur, Rajasthan | April 2026
In a serious development concerning public health, the Food Safety and Drug Administration (FSDA) in Rajasthan has issued an alert after several medicines and cosmetic products were found to be “Not of Standard Quality” (NSQ) during recent testing and surveillance.
The action comes amid intensified monitoring by the state’s health department to ensure that unsafe or ineffective products do not reach consumers.
Substandard Medicines and Cosmetics Identified
According to official data, multiple drug samples and cosmetic products failed quality tests conducted by authorities. These products did not meet the prescribed standards under the Drugs and Cosmetics Act, raising concerns over their safety and effectiveness.
Earlier testing in Jaipur had already flagged 7 medicines and 3 cosmetic products as substandard, prompting authorities to issue immediate withdrawal instructions.
More Read
Officials confirmed that details of such products are regularly circulated to drug control officers across districts to ensure quick action and prevent further sale.
Statewide Alert and Strict Instructions
Following the findings, the FSDA has:
- Issued alerts to all district drug control authorities
- Directed immediate withdrawal of substandard batches from the market
- Initiated action against manufacturers and suppliers
- Ordered strict compliance checks at medical stores and distribution points
In recent cases, authorities have also shared findings with national regulators to prevent interstate circulation of such products.
More Read
Public Health Concerns Rise
Health experts warn that substandard medicines can have serious consequences, especially when used for treating common illnesses like fever, cough, infections, and chronic diseases.
Recent reports indicate that even drugs used for critical conditions such as diabetes, hypertension, and infections have failed quality tests in Rajasthan.
Similarly, substandard cosmetic products can cause skin damage, allergies, and long-term health issues.
Crackdown on Pharma Companies
The Rajasthan government has been taking strict action against companies found supplying poor-quality products. In recent months:
- Several pharmaceutical firms have been blacklisted or banned
- Dozens of medicines have been removed from circulation
- Legal action has been initiated under the Drugs and Cosmetics Act
In 2025 alone, around 40 medicines were banned and multiple firms debarred for failing quality standards—marking one of the biggest crackdowns in the state.
Increased Surveillance and Testing
Authorities have intensified random sampling and laboratory testing across the state. Drug inspectors are actively collecting samples from:
More Read
- Medical stores
- Hospitals
- Distribution warehouses
Only batches that pass strict laboratory testing are allowed for sale, while failed samples are immediately flagged and removed.
Government’s Stand
Officials have reiterated a zero-tolerance policy towards substandard medicines and cosmetics. The government emphasized that ensuring the safety of medicines—especially under public health schemes—remains a top priority.
Citizens have been advised to:
- Purchase medicines only from licensed pharmacies
- Check batch numbers and expiry dates
- Report any suspected low-quality products to authorities
Conclusion
The latest FSDA alert highlights ongoing concerns over the quality of medicines and cosmetics in Rajasthan. While strict monitoring and enforcement actions are underway, the issue underscores the need for stronger regulation and accountability in the pharmaceutical supply chain.
Ensuring safe and effective products remains critical to protecting public health and maintaining trust in the healthcare system.